Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men

por Shankara Narayana, Nandini, Ly, Lam P, Jayadev, Veena, Fennell, Carolyn, Savkovic, Sasha, Conway, Ann J, Handelsman, David J
Publicado 2021

FRI434 Long-term Self-reported Outcomes Of Randomized Testosterone (T) vs Placebo (P) Treatment In The T4DM Study

por Handelsman, David J, Grossmann, Mathis, Yeap, Bu Beng, Stuckey, Bronwyn G A, Shankara-Narayana, Nandini, Conway, Ann J, Inder, Warrick, McLachlan, Robert I, Allan, Carolyn A, Jenkins, Alicia, Jesudason, David R, Bracken, Karen, Robledo, Kristy, Wittert, Gary A
Publicado 2023